for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Markets News

BRIEF-Oncolytics Biotech Reports Qtrly Basic And Diluted Loss Per Common Share Of $0.03

May 11 (Reuters) - Oncolytics Biotech Inc:

* ONCOLYTICS BIOTECH® REPORTS 2018 FIRST QUARTER RESULTS

* ONCOLYTICS BIOTECH INC - QTRLY BASIC AND DILUTED LOSS PER COMMON SHARE $0.03

* ONCOLYTICS BIOTECH INC - AT MARCH 31, 2018, CO REPORTED $7.7 MILLION IN CASH AND CASH EQUIVALENTS

* ONCOLYTICS BIOTECH INC - ALL DOLLAR AMOUNTS ARE CANADIAN

* ONCOLYTICS - ADVANCED PLANS TO RELIST CO’S SHARES ON NASDAQ CAPITAL MARKET EXCHANGE, CONTINUES TO EVALUATE TIMING OF THIS ACTION Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up